Coldstream Capital Management Cut By $528,528 Its Danaher Del (DHR) Stake, Ecor1 Capital Increased Chimerix (CMRX) Stake

June 19, 2017 - By Winifred Garcia

Ecor1 Capital Llc increased Chimerix Inc (CMRX) stake by 136.71% reported in 2016Q4 SEC filing. Ecor1 Capital Llc acquired 817,625 shares as Chimerix Inc (CMRX)’s stock declined 21.34%. The Ecor1 Capital Llc holds 1.42 million shares with $6.51M value, up from 598,062 last quarter. Chimerix Inc now has $244.74M valuation. The stock rose 2.00% or $0.1 reaching $5.11 per share. About 69,577 shares traded. Chimerix Inc (NASDAQ:CMRX) has risen 3.54% since June 19, 2016 and is uptrending. It has underperformed by 13.16% the S&P500.

Coldstream Capital Management Inc decreased Danaher Corp Del (DHR) stake by 35.33% reported in 2016Q4 SEC filing. Coldstream Capital Management Inc sold 6,864 shares as Danaher Corp Del (DHR)’s stock declined 2.27%. The Coldstream Capital Management Inc holds 12,563 shares with $978,000 value, down from 19,427 last quarter. Danaher Corp Del now has $59.20 billion valuation. The stock rose 0.83% or $0.7 reaching $85.18. About 726,403 shares traded. Danaher Corporation (NYSE:DHR) has risen 10.62% since June 19, 2016 and is uptrending. It has underperformed by 6.08% the S&P500.

Since December 27, 2016, it had 0 buys, and 1 sale for $464,367 activity. MARIO ERNEST also sold $464,367 worth of Chimerix Inc (NASDAQ:CMRX) shares.

Investors sentiment decreased to 0.94 in 2016 Q4. Its down 0.11, from 1.05 in 2016Q3. It dived, as 16 investors sold CMRX shares while 31 reduced holdings. 12 funds opened positions while 32 raised stakes. 30.20 million shares or 8.41% less from 32.97 million shares in 2016Q3 were reported. Voya Inv Mngmt Limited holds 24,677 shares or 0% of its portfolio. Jpmorgan Chase & Communications has invested 0% of its portfolio in Chimerix Inc (NASDAQ:CMRX). The California-based Ecor1 Cap has invested 2.18% in Chimerix Inc (NASDAQ:CMRX). Credit Suisse Ag owns 37,882 shares. Citadel Advisors Ltd Llc reported 96,633 shares or 0% of all its holdings. Geode Capital Mngmt Lc holds 0% of its portfolio in Chimerix Inc (NASDAQ:CMRX) for 305,486 shares. New York State Common Retirement Fund has 0% invested in Chimerix Inc (NASDAQ:CMRX) for 36,400 shares. 26,300 were reported by Virginia Retirement System Et Al. 184,679 are held by Blackrock Inv Management Ltd Liability Co. Legal General Gru Public Ltd Com stated it has 0% in Chimerix Inc (NASDAQ:CMRX). Dimensional Fund Advsr Ltd Partnership stated it has 0% of its portfolio in Chimerix Inc (NASDAQ:CMRX). Invesco reported 70,016 shares. Excalibur Mngmt Corp invested in 14,400 shares. California Public Employees Retirement System reported 80,600 shares or 0% of all its holdings. Glenmede Na invested in 6,992 shares or 0% of the stock.

Among 7 analysts covering Chimerix Inc (NASDAQ:CMRX), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Chimerix Inc had 16 analyst reports since August 5, 2015 according to SRatingsIntel. JP Morgan downgraded the stock to “Neutral” rating in Tuesday, December 29 report. The firm earned “Overweight” rating on Tuesday, December 29 by Barclays Capital. The rating was downgraded by Morgan Stanley to “Underweight” on Tuesday, February 23. As per Tuesday, August 18, the company rating was initiated by FBR Capital. The rating was downgraded by Barclays Capital to “Equal-Weight” on Tuesday, February 23. The rating was downgraded by FBR Capital on Monday, December 28 to “Mkt Perform”. FBR Capital maintained the shares of CMRX in report on Tuesday, February 23 with “Mkt Perform” rating. UBS initiated the stock with “Buy” rating in Thursday, December 17 report. Morgan Stanley downgraded the shares of CMRX in report on Monday, October 5 to “Equal-Weight” rating. The stock of Chimerix Inc (NASDAQ:CMRX) has “Buy” rating given on Thursday, August 6 by Brean Capital.

Ecor1 Capital Llc decreased Chemocentryx Inc stake by 60,000 shares to 118,000 valued at $873,000 in 2016Q4. It also reduced Cytokinetics Inc (NASDAQ:CYTK) stake by 791,775 shares and now owns 54,879 shares. Nabriva Therapeutics Ag was reduced too.

Coldstream Capital Management Inc increased Verizon Communications In (NYSE:VZ) stake by 31,679 shares to 49,125 valued at $2.62M in 2016Q4. It also upped Ishares Tr (HEFA) stake by 402,177 shares and now owns 1.48M shares. Merck & Co Inc (NYSE:MRK) was raised too.

Since February 1, 2017, it had 0 insider purchases, and 12 selling transactions for $35.92 million activity. 37,870 shares were sold by LUTZ ROBERT S, worth $3.24 million on Thursday, February 23. Raskas Daniel sold $2.87M worth of stock or 34,168 shares. $84,533 worth of Danaher Corporation (NYSE:DHR) was sold by Ellis Brian W. SCHWIETERS JOHN T sold 10,578 shares worth $891,620. Shares for $891,937 were sold by LOHR WALTER G on Wednesday, February 15. The insider COMAS DANIEL L sold 10,250 shares worth $882,443. Lalor Angela S sold $910,212 worth of stock or 10,815 shares.

Among 15 analysts covering Danaher Corporation (NYSE:DHR), 11 have Buy rating, 0 Sell and 4 Hold. Therefore 73% are positive. Danaher Corporation had 48 analyst reports since July 28, 2015 according to SRatingsIntel. As per Friday, April 21, the company rating was maintained by RBC Capital Markets. The stock of Danaher Corporation (NYSE:DHR) earned “Overweight” rating by Barclays Capital on Monday, April 18. On Friday, November 11 the stock rating was upgraded by Cowen & Co to “Outperform”. RBC Capital Markets maintained Danaher Corporation (NYSE:DHR) rating on Friday, May 27. RBC Capital Markets has “Sector Perform” rating and $99 target. Stifel Nicolaus maintained the shares of DHR in report on Friday, October 23 with “Buy” rating. On Monday, April 25 the stock rating was maintained by Sterne Agee CRT with “Neutral”. As per Friday, October 23, the company rating was maintained by RBC Capital Markets. The stock has “Buy” rating by Citigroup on Friday, February 24. Credit Suisse maintained Danaher Corporation (NYSE:DHR) rating on Thursday, May 25. Credit Suisse has “Buy” rating and $93 target. The stock of Danaher Corporation (NYSE:DHR) earned “Overweight” rating by Barclays Capital on Friday, October 23.

Investors sentiment increased to 1.34 in Q4 2016. Its up 0.03, from 1.31 in 2016Q3. It improved, as 55 investors sold DHR shares while 315 reduced holdings. 89 funds opened positions while 406 raised stakes. 508.19 million shares or 0.53% more from 505.49 million shares in 2016Q3 were reported. Moreover, Meiji Yasuda Life Ins Com has 0.29% invested in Danaher Corporation (NYSE:DHR) for 22,389 shares. Private Wealth Partners Ltd accumulated 2.78% or 150,378 shares. Wetherby Asset invested in 15,377 shares. Advantus Mngmt Inc holds 0.13% or 60,953 shares in its portfolio. Stevens Cap Management LP reported 298,318 shares. Bradley Foster Sargent Inc Ct, Connecticut-based fund reported 415,299 shares. Redmond Asset Ltd Liability Corporation stated it has 0.51% of its portfolio in Danaher Corporation (NYSE:DHR). Fmr Ltd Llc invested in 0.2% or 19.39M shares. Sei Invs has 0.13% invested in Danaher Corporation (NYSE:DHR). Sawgrass Asset Management Ltd Liability reported 1.87% of its portfolio in Danaher Corporation (NYSE:DHR). Amalgamated Commercial Bank, New York-based fund reported 46,896 shares. Confluence Wealth Management Lc has 9,275 shares for 0.36% of their portfolio. Mai invested in 22,585 shares or 0.13% of the stock. Amf Pensionsforsakring Ab stated it has 900,700 shares or 0.82% of all its holdings. Earnest Prns stated it has 320 shares.

Analysts await Danaher Corporation (NYSE:DHR) to report earnings on July, 24. They expect $0.97 EPS, down 22.40% or $0.28 from last year’s $1.25 per share. DHR’s profit will be $674.15 million for 21.95 P/E if the $0.97 EPS becomes a reality. After $0.85 actual EPS reported by Danaher Corporation for the previous quarter, Wall Street now forecasts 14.12% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: